For Immediate Release Contact firstname.lastname@example.org
September 19, 2011
TUSTIN, Calif., Sept. 19, 2011 – Performing cardiac catheterizations through the radial artery is proven to lower the risk of vascular complications, reduce major bleeding and improve patient recovery time when compared to femoral access. Shannon Medical Center, in San Angelo, Texas, installed Toshiba America Medical Systems, Inc.’s InfinixTM CF-i single plane vascular X-ray system to conduct radial interventions more easily and improve patient safety and outcomes while reducing costs. Toshiba’s Infinix-i system enables Shannon to use the radial approach in more than 65 percent of its cases.
Because the Infinix CF-i single plane is a dedicated cardiac cath lab featuring a floor-mounted five-axis positioner, the system makes it possible to obtain images without repositioning patients. This is particularly important during radial interventions, allowing clinicians unencumbered patient access and an ergonomic setup for both right- and left-side approaches. The Infinix-i monitors float freely around the system and can be positioned for easy viewing regardless of procedure type.
“Radial artery access is undeniably the future of cardiac catheterization, and the flexibility and image quality of the Toshiba Infinix-i system facilitates safe and efficient interventions,” said Dr. J. Chris McClish, interventional cardiologist, Shannon Medical Center. “For example, the system’s lateral movement and fingertip-to-fingertip coverage enable catheter exchanges during procedures without adjusting the table and changing alignment. Radial is our default access site now, reducing complications and improving patient satisfaction.”
Additionally, Shannon’s increased use of radial access brings financial benefits. Radial interventions reduce post-procedure hospital stays and decrease procedure costs. Shannon has also experienced an increase in patient referrals, as they are the only facility in the area performing radial interventions.
“The Infinix CF-i single plane vascular X-ray system’s unique design is an example of Toshiba’s commitment to providing imaging solutions that improve patient care and safety and enhance efficiency, resulting in lower healthcare costs,” said Stephen Bumb, director, X-ray Vascular Business Unit, Toshiba.
For more than 75 years, Shannon Medical Center has served West Texas, growing with the community and serving its healthcare needs. Its facility is licensed for 400 beds and provides a variety of clinical services to meet each patient’s needs. Shannon Medical Center is the designated Lead Level 3 Trauma Center for the region, has a nationally-recognized Intensive Care Unit, provides critical care to newborns as young as 28 weeks, performs state-of-the-art diagnostics in the radiology department, and provides complete testing and surgical capabilities for cardiology patients among many more services.
With headquarters in Tustin, Calif., Toshiba America Medical Systems (TAMS) markets, sells, distributes and services diagnostic imaging systems, and coordinates clinical diagnostic imaging research for all modalities in the United States. For more information, visit the TAMS website at www.medical.toshiba.com.
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultrasound, nuclear medicine, and MRI systems, as well as information systems for medical institutions. Toshiba Medical Systems Corporation has been providing medical products for over 80 years. Toshiba Medical Systems Corporation is a wholly owned subsidiary of Toshiba.
Toshiba is a diversified manufacturer and marketer of advanced electronic and electrical products, spanning digital products, such as LCD TVs, notebook PCs and hard disc drives; electronic devices and components, such as semiconductors; social infrastructure systems, including power generation systems, and home appliances. Toshiba was founded in 1875, and today operates a global network of more than 490 companies, with 203,000 employees worldwide and annual sales surpassing 6.3 trillion yen (US$77 billion).